BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33428640)

  • 1. Proportion of children aged 9-59 months reached by the 2017 measles supplementary immunization activity among the children with or without history of measles vaccination in Lilongwe district, Malawi.
    Kainga HW; Ssendagire S; Ssanyu JN; Nabukeera S; Namuhani N; Mangen FW
    PLoS One; 2021; 16(1):e0243137. PubMed ID: 33428640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA; François J; Wannemuehler K; Magloire R; Danovaro-Holliday MC; Flannery B; Cavallaro KF; Fitter DL; Purcell N; Dismer A; Tappero JW; Vertefeuille JF; Hyde TB
    Trop Med Int Health; 2014 Sep; 19(9):1105-15. PubMed ID: 25041586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin.
    Kaucley L; Levy P
    Cost Eff Resour Alloc; 2015; 13():14. PubMed ID: 26300696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002.
    Vijayaraghavan M; Martin RM; Sangrujee N; Kimani GN; Oyombe S; Kalu A; Runyago A; Wanjau G; Cairns L; Muchiri SN
    Health Policy; 2007 Sep; 83(1):27-36. PubMed ID: 17174435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local discrepancies in measles vaccination opportunities: results of population-based surveys in Sub-Saharan Africa.
    Grout L; Conan N; Juan Giner A; Hurtado N; Fermon F; N'Goran A; Grellety E; Minetti A; Porten K; Grais RF
    BMC Public Health; 2014 Feb; 14():193. PubMed ID: 24559281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic.
    Yang Y; Kostandova N; Mwansa FD; Nakazwe C; Namukoko H; Sakala C; Bobo P; Masumbu PK; Nachinga B; Ngula D; Carcelen AC; Prosperi C; Winter AK; Moss WJ; Mutembo S
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K
    PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of measles vaccination coverage among children 6-59 months of age in the Democratic Republic of the Congo.
    Ashbaugh HR; Hoff NA; Doshi RH; Alfonso VH; Gadoth A; Mukadi P; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Gerber SK; Cherry JD; Rimoin AW
    Vaccine; 2018 Jan; 36(4):587-593. PubMed ID: 29248265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaps in the 2010 measles SIA coverage among migrant children in Beijing: evidence from a parental survey.
    Hu X; Xiao S; Chen B; Sa Z
    Vaccine; 2012 Aug; 30(39):5721-5. PubMed ID: 22819988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles in Brazil.
    EPI Newsl; 1984 Jun; 6(3):1-3. PubMed ID: 12267944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey.
    Lowther SA; Curriero FC; Kalish BT; Shields TM; Monze M; Moss WJ
    Lancet; 2009 Mar; 373(9668):1025-32. PubMed ID: 19211140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles outbreak in a northern Pakistani village: epidemiology and vaccine effectiveness.
    Murray M; Rasmussen Z
    Am J Epidemiol; 2000 Apr; 151(8):811-9. PubMed ID: 10965978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China.
    Chong KC; Zhang C; Zee BC; Luo T; Wang L; Tam GC; Jia KM; Sun R; Wang MH; Guan X
    Vaccine; 2017 Feb; 35(7):1024-1029. PubMed ID: 28111146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda.
    Waibale P; Bowlin SJ; Mortimer EA; Whalen C
    Int J Epidemiol; 1999 Apr; 28(2):341-6. PubMed ID: 10342701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious Disease Risk and Vaccination in Northern Syria after 5 Years of Civil War: The MSF Experience.
    de Lima Pereira A; Southgate R; Ahmed H; O'Connor P; Cramond V; Lenglet A
    PLoS Curr; 2018 Feb; 10():. PubMed ID: 29511602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles sero-surveillance during mass immunisation campaign in Malawi.
    Takechi M; Matsuo M; Butao D; Zungu IL; Chakanika I; Michongwe J
    East Afr Med J; 2001 Jan; 78(1):4-8. PubMed ID: 11320764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles susceptibility in children in Karachi, Pakistan.
    Sheikh S; Ali A; Zaidi AK; Agha A; Khowaja A; Allana S; Qureshi S; Azam I
    Vaccine; 2011 Apr; 29(18):3419-23. PubMed ID: 21396902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.